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Description
The gene encodes a guanine nucleotide exchange factor for Rho GTPase; 985 amino acids; NH2-Protein kinase C conserved region 1 (zinc finger motif), Dblhomologous domain (DH domain), pleckstrin homology (PH) domain -coiled coil c-terminus domain -COOH.
Expression
Wide (cochlea, bone marrow, lymph, blood, lung, ovary, cranial nerve, lymph node, colon, spleen, kidney, muscle, eye, bone, cervix, nerve, adrenal gland, heart, skin, thyroid, uterus, testis, pancreas, brain, mouth, stomach, thymus, pharynx, prostate, vascular, mammary gland, placenta) .
Localisation
Microtubules.
Function
ARHGEF2/GEF-H1 belongs to a Dbl family of Rho activators and exhibits Rho-specific GDP/GTP exchange activity for RhoA but not for Rac1 or Cdc42. ARHGEF2/GEF-H1 activity is downregulated by interaction of its C-terminus with microtubules. Therefore, ARHGEF2/GEF-H1 links changes in microtubule integrity to Rho-dependent regulation of the actin cytoskeleton. Activated RhoA transduces various signals into downstream signaling cascades, such as cytoskeleton reorganization, cellular invasion, and cell proliferation, all of which contribute to cancer progression. Like other RhoGEF Dbl members, ARHGEF2/GEF-H1 possesses the Dbl-homology (DH) domain responsible for its GEF activity the pleckstrin-homology (PH) domain, adjacent and C-terminal to the DH domain. In addition, ARHGEF2/GEF-H1 also contains a cysteinerich zinc finger-like motif at its amino terminus and a proline-rich coiled coil domain at its carboxy terminus. The N-and C-terminal motifs mediate microtubule localization of ARHGEF2/GEF-H1. Point mutated (cys53 to arg) in a zinc finger-like motif, as well as Nand C-terminally truncated ARHGEF2/GEF-H1 proteins are loosing ability to bind microtubules. These truncated forms have no affect on microtubule stability, and displaying even higher GEF activity then microtubule-bound forms. The coiled coil domain at Cterminus may interact with SH3 domain-containing proteins and has a potential binding site for 14-3-3 proteins.
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A schematics representing the domain structure of full length ARHGEF2/GEF-H1
The ser885 within the 14-3-3-binding site is a phosphorylation site for p21-activated kinase 1 (PAK1), an effector of RAC and CDC42 GTPases. The phosphorylation of ARHGEF2/GEFH1 by PAK may coordinate Rac/Cdc42-and Rho-dependent signaling pathways.
Homology
The high level of homology has been shown for three known rho/rac guanine nucleotide exchange factors originated from human, mouse and dog.
Implicated in
Gastrointestinal mesenchymal malignancies
Disease Microarray analysis identified ARHGEF2/GEF-H1 as one of response markers for a treatment of gastrointestinal stromal tumors, implicating its role in the development of gastrointestinal mesenchymal malignancies. Oncogenesis A cell line transformed by ARHGEF2/GEF-H1 transfection can induce tumor development after injection into nude mice. The increased ARHGEF2/GEF-H1 expression was found contributing to the tumor progression phenotype associated with the p53 mutation.
